Alexa, teach me about diabetes: smart speaker trial aims to improve blood sugar in older adults
NCT ID NCT07734259
First seen Jul 29, 2026 · Last updated Jul 30, 2026 · Updated 1 time
Summary
This pilot study tests whether a voice-activated smart speaker can help adults aged 50 and older with poorly controlled type 2 diabetes improve their blood sugar levels. Participants receive weekly diabetes education and skills training calls through the smart speaker for 12 weeks. Researchers will measure changes in blood sugar, blood pressure, and cholesterol, as well as feelings of depression, loneliness, and social isolation.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- weekly diabetes education and skills training calls delivered through a voice-activated, touchscreen-controlled smart speaker
- What this could lead to
- If it works, this could offer a simple, at-home way to help older adults with diabetes better manage their blood sugar and overall health.
- What could go wrong
- This is a very small pilot study with only 30 participants and no comparison group, so results may not apply broadly. The intervention depends on participants being willing and able to use the smart speaker technology.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Daily pill could offer new hope for weight loss in east asian adults
- Could your bone health decide if a dental implant lasts?
- Blood test could predict who faces rapid kidney decline in diabetes
- Blood test may predict kidney decline in diabetes — a large trial investigates
- Hormone clue may unmask kidney danger in diabetes
- Can a single pill tackle both fatty liver and diabetes?